Literature DB >> 20802152

Cutting edge: Expression of the transcription factor E74-like factor 4 is regulated by the mammalian target of rapamycin pathway in CD8+ T cells.

Takeshi Yamada1, Kirsten Gierach, Ping-Hsien Lee, Xiaohong Wang, H Daniel Lacorazza.   

Abstract

T cell receptor activation inhibits expression of the E74-like factor (ELF) 4 and Krüppel-like factor 4 genes to release naive CD8(+) T cells from their quiescent state. In this study, we show that ELF4 controls the ERK-mediated proliferative response by maintaining normal levels of dual-specificity phosphatases 1 and 5 in CD8(+) T cells. In activated CD8(+) T cells, the mammalian target of rapamycin pathway inhibits ELF4 and Krüppel-like factor 4 expression downstream of ERK and PI3K signaling. Our findings demonstrate that rapamycin could be used to modulate expression of this transcriptional network involved in cell-cycle regulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20802152      PMCID: PMC2943983          DOI: 10.4049/jimmunol.1000718

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway.

Authors:  A F Buckley; C T Kuo; J M Leiden
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

Review 2.  DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response.

Authors:  Roland Lang; Michael Hammer; Jörg Mages
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

3.  The dual specificity phosphatase transcriptome of the murine thymus.

Authors:  Melinda B Tanzola; Gilbert J Kersh
Journal:  Mol Immunol       Date:  2005-03-25       Impact factor: 4.407

4.  A synthetic inhibitor of the mitogen-activated protein kinase cascade.

Authors:  D T Dudley; L Pang; S J Decker; A J Bridges; A R Saltiel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

5.  Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells.

Authors:  D Tzachanis; G J Freeman; N Hirano; A A van Puijenbroek; M W Delfs; A Berezovskaya; L M Nadler; V A Boussiotis
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

6.  The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells.

Authors:  H Daniel Lacorazza; Takeshi Yamada; Yan Liu; Yasuhiko Miyata; Mariela Sivina; Juliana Nunes; Stephen D Nimer
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

Review 7.  Molecular pathogenesis of T-cell leukaemia and lymphoma.

Authors:  Iannis Aifantis; Elizabeth Raetz; Silvia Buonamici
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

8.  T-cell development and function are modulated by dual specificity phosphatase DUSP5.

Authors:  Panu E Kovanen; Jérôme Bernard; Amin Al-Shami; Chengyu Liu; Julie Bollenbacher-Reilley; Lynn Young; Cynthia Pise-Masison; Rosanne Spolski; Warren J Leonard
Journal:  J Biol Chem       Date:  2008-04-21       Impact factor: 5.157

9.  MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells.

Authors:  C E Whitehurst; T D Geppert
Journal:  J Immunol       Date:  1996-02-01       Impact factor: 5.422

10.  Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking.

Authors:  Linda V Sinclair; David Finlay; Carmen Feijoo; Georgina H Cornish; Alex Gray; Ann Ager; Klaus Okkenhaug; Thijs J Hagenbeek; Hergen Spits; Doreen A Cantrell
Journal:  Nat Immunol       Date:  2008-04-06       Impact factor: 25.606

View more
  13 in total

Review 1.  Novel tumor-suppressor function of KLF4 in pediatric T-cell acute lymphoblastic leukemia.

Authors:  Ye Shen; Taylor J Chen; H Daniel Lacorazza
Journal:  Exp Hematol       Date:  2017-05-04       Impact factor: 3.084

2.  Kruppel-like factor 4 (KLF4) promotes the survival of natural killer cells and maintains the number of conventional dendritic cells in the spleen.

Authors:  Chun Shik Park; Ping-Hsien Lee; Takeshi Yamada; Audrea Burns; Ye Shen; Monica Puppi; H Daniel Lacorazza
Journal:  J Leukoc Biol       Date:  2012-02-17       Impact factor: 4.962

Review 3.  Regulation of immune responses by mTOR.

Authors:  Jonathan D Powell; Kristen N Pollizzi; Emily B Heikamp; Maureen R Horton
Journal:  Annu Rev Immunol       Date:  2011-11-29       Impact factor: 28.527

4.  The transcription factor E74-like factor controls quiescence of endothelial cells and their resistance to myeloablative treatments in bone marrow.

Authors:  Mariela Sivina; Takeshi Yamada; Chun Shik Park; Monica Puppi; Suleyman Coskun; Karen Hirschi; H Daniel Lacorazza
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-02-24       Impact factor: 8.311

5.  The transcription factor E74-like factor 4 suppresses differentiation of proliferating CD4+ T cells to the Th17 lineage.

Authors:  Ping-Hsien Lee; Monica Puppi; Kimberly S Schluns; Li-Yuan Yu-Lee; Chen Dong; H Daniel Lacorazza
Journal:  J Immunol       Date:  2013-11-20       Impact factor: 5.422

6.  Differential roles of KLF4 in the development and differentiation of CD8+ T cells.

Authors:  Maksim Mamonkin; Ye Shen; Ping-Hsien Lee; Monica Puppi; Chun Shik Park; H Daniel Lacorazza
Journal:  Immunol Lett       Date:  2013-09-25       Impact factor: 3.685

Review 7.  Metabolic switching and fuel choice during T-cell differentiation and memory development.

Authors:  Gerritje J W van der Windt; Erika L Pearce
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

8.  Circadian rhythm influences induction of trained immunity by BCG vaccination.

Authors:  L Charlotte J de Bree; Vera P Mourits; Valerie Acm Koeken; Simone Jcfm Moorlag; Robine Janssen; Lukas Folkman; Daniele Barreca; Thomas Krausgruber; Victoria Fife-Gernedl; Boris Novakovic; Rob Jw Arts; Helga Dijkstra; Heidi Lemmers; Christoph Bock; Leo Ab Joosten; Reinout van Crevel; Christine S Benn; Mihai G Netea
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

9.  Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway.

Authors:  Y Shen; C S Park; K Suppipat; T-A Mistretta; M Puppi; T M Horton; K Rabin; N S Gray; J P P Meijerink; H D Lacorazza
Journal:  Leukemia       Date:  2016-11-22       Impact factor: 12.883

Review 10.  The role of mechanistic target of rapamycin (mTOR) complexes signaling in the immune responses.

Authors:  Ghada A Soliman
Journal:  Nutrients       Date:  2013-06-19       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.